Granules India
GRANULES · Pharma > Pharmaceuticals & Drugs · Chairman: Krishna Prasad Chigurupati · MD: Krishna Prasad Chigurupati · Listing date: June 21, 2005 · Employees: 3369 · Hyderabad · http://www.granulesindia.com

Stock Price vs Company Growth
1d
1.4%
1w
1.1%
1m
7.3%
3m
9.7%
6m
20.8%
1y
54.8%
5y
36.8%
10y
23.9%
all
27.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 592 1.4%
523
627
Company Overview

Sales
4,478 Cr
Growth: 7.7%
Profit after Tax
487 Cr
Growth: -1.0%
Mid Cap
14,351 Cr
P/E: 29.5x
Industry P/E: 37.3x
Fundamentals

Sales (Cr) ₹ 4,478
Growth 7.7%
EBITDA 21.6%
P/S 3.2x
Dividend 0.5%
P/E 29.5x
Book Value ₹ 143
PEG Ratio 3.8x
ROE 14.8%
P/B 4.2x
Shareholding Pattern

Institutions
Government Pension Fund Global
3.01 %
Fidelity Funds - Asian Smaller Companies Pool
1.55 %
Mahima Stocks Private Limited
1.49 %
Basava Sankara Rao Kolli
1.21 %
Iepf
0.1 %
Promoters
Krishna Prasad Chigurupati
34.84 %
Chigurupati Uma Devi
3.82 %
Tyche Investments Private Limited
1.47 %
Chigurupati Pragnya
0.76 %
Chigurupati Priyanka
0.75 %
Others
Qualified Instituional Buyer
0.15 %
Increase    Decrease    No change
Company Profile Detailed

Granules India is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India today. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs).
Investors (124)
Followers (24)